FDA 483 - Scot D. Miller, D.O. - May 27, 2021

An FDA inspection of Scott D. Miller, MD, a clinical investigator in Akron, OH, identified a significant issue regarding informed consent. Specifically, study-related procedures were performed on a subject prior to the informed consent form being signed. This indicates a failure to adhere to regulations concerning the protection of human subjects.